FDA OKs new Johnson & Johnson treatment for psoriasis

  • Jul. 14, 2017 12:30 a.m.

FDA OKs new Johnson &Johnson treatment for psoriasis

TRENTON, N.J. — U.S. regulators approved a new psoriasis drug from Johnson &Johnson Thursday, giving people with the itchy and painful condition another treatment option.

Johnson &Johnson said that in one patient study, about seven in 10 patients getting the drug, Tremfya, had clear or nearly clear skin after 24 weeks of treatment. That compares with about four in 10 patients receiving rival AbbVie’s Humira, which treats several immune disorders and is the world’s top selling drug.

Tremfya, which is injected every eight weeks, can cause infections and other serious side effects. Because it suppresses part of the immune system, it can increase the risk of developing tuberculosis and some types of cancer.

The drug, which has the chemical name guselkumab, will cost $9,684 per dose, or about $58,100 per year, without insurance. That’s comparable to Humira, which costs about $59,200 a year.

More than 7.5 million Americans are estimated to have psoriasis, a chronic inflammatory condition in which overproduction of skin cells causes raised red lesions called plaques, along with frequent pain, itching and burning sensations. Tremfya was able to both clear up lesions and help relieve those symptoms.

Johnson &Johnson, based in New Brunswick, New Jersey, sells other immune disorder treatment such as Remicade and Stelara for conditions including Crohn’s disease, ulcerative colitis and rheumatoid arthritis.

Just Posted

Police informer talks about his role in Castor undercover sting

Jason Klaus and Joshua Frank were convicted of triple murders last month

City of Red Deer invites residents to Let’s Talk

Interactive public forum to be held April 7

Lessons in altruism learned by Red Deer students

St. Francis of Assisi School launches community foundation project

Sylvan Lake council approves fire pits and mobile stage

Large fire pits for group gatherings will be located on pier next winter

WATCH: Red Deer Taboo Show in full swing

The Red Deer Taboo Show is in full swing at Westerner Park.… Continue reading

Driver crashes into Red Deer business while fleeing police

A car smashed through a Red Deer business’ front window while fleeing… Continue reading

VIDEO: ‘New wave’ of anti-pipeline protests return to Trans Mountain facility

About 100 demonstrators with Protect the Inlet marched to the Burnaby terminal Saturday

Groups expressing concern about jobs funding rules await final decision

OTTAWA — It was Valentine’s Day when an Alberta church was told… Continue reading

Superstore chain Fred Meyer to stop selling guns, ammunition

PORTLAND, Ore. — Superstore company Fred Meyer will stop selling guns and… Continue reading

Wickenheiser says strengthening Olympic hockey bridge behind North Korea trip

CALGARY — Hayley Wickenheiser was conflicted about the unified Korean women’s hockey… Continue reading

Watch: Volcanic thunder is real, and this is what it sounds like

Behold, the rumble of volcanic thunder. No, this is not the sound… Continue reading

Cosmetics giant L’Oreal buys Toronto augmented reality startup ModiFace

TORONTO — When University of Toronto engineering professor Parham Aarabi first began… Continue reading

Most Read

Five-day delivery plus unlimited digital access for $185 for 260 issues (must live in delivery area to qualify) Unlimited Digital Access 99 cents for the first four weeks and then only $15 per month Five-day delivery plus unlimited digital access for $15 a month